Concurrent ERBB2 missense mutations D769Y and D742 N Are Novel Acquired Mechanism of Gefitinib Resistance but Responds to Gefitinib plus Pyrotinib. (June 2020)

Record Type:: Journal Article
Title:: Concurrent ERBB2 missense mutations D769Y and D742 N Are Novel Acquired Mechanism of Gefitinib Resistance but Responds to Gefitinib plus Pyrotinib. (June 2020)
Main Title:: Concurrent ERBB2 missense mutations D769Y and D742 N Are Novel Acquired Mechanism of Gefitinib Resistance but Responds to Gefitinib plus Pyrotinib
Authors:: Zhou, Yuling
Jiang, Wenjuan
Yang, Nong
Zhang, Yongchang
Abstract:
Is Part Of:: Lung cancer. Volume 144(2020)
Journal:: Lung cancer
Issue:: Volume 144(2020)
Issue Display:: Volume 144, Issue 2020 (2020)
Year:: 2020
Volume:: 144
Issue:: 2020
Issue Sort Value:: 2020-0144-2020-0000
Page Start:: 90
Page End:: 91
Publication Date:: 2020-06
Subjects:: Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:: http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.lungcan.2020.04.003 ↗
Languages:: English
ISSNs:: 0169-5002
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13558.xml